Astrana Health(ASTH.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Astrana Health
ASTH.US
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists.
386.88 B
ASTH.USMarket value -Rank by Market Cap -/-

Financial Score

18/01/2026 Update
B
Health Care ServicesIndustry
Industry Ranking14/82
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE1.29%D
    • Profit Margin0.33%C
    • Gross Margin10.17%E
  • Growth ScoreB
    • Revenue YoY68.17%A
    • Net Profit YoY-84.73%E
    • Total Assets YoY74.05%A
    • Net Assets YoY9.39%B
  • Cash ScoreA
    • Cash Flow Margin30370.68%A
    • OCF YoY68.17%A
  • Operating ScoreA
    • Turnover1.64A
  • Debt ScoreE
    • Gearing Ratio75.20%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Insider Activity Update: David Schmidt Executes Options Exercise, Resulting In $431K At Astrana Health

    David Schmidt, Director at Astrana Health (NASDAQ:ASTH), exercised stock options for 20,000 shares at an exercise price of $5.79, valued at $431,800, according to a recent SEC filing. Astrana Health's shares are currently priced at $27.38. The company reported a revenue growth of 99.71% over the last three months, but has a low gross margin of 10.17% and an EPS of 0.01. Its P/E ratio is 144.11, indicating potential overvaluation, while the P/S ratio of 0.46 suggests possible undervaluation. Insider transactions can influence investment decisions, but should not be the sole factor.

    benzinga_article·
    US
    ASTH
    -1.57%
    benzinga_article·
    US
    ASTH
    -1.57%

    Astrana Health Touts Delegated Risk “Single Payer” Model, Prospect Synergies, Reiterates 2025 Guide

    Astrana Health (NASDAQ:ASTH) executives presented the company's delegated risk model and growth strategy, emphasizing a shift towards a "single payer" approach to address systemic issues in U.S. healthcare. The model aims to streamline payments and administrative functions, benefiting members, providers, and payers. Astrana operates in 16 markets, serving 1.6 million members with a focus on value-based care. The company is integrating Prospect Health, a $707 million acquisition, and aims for $12 million to $15 million in synergies. Astrana's technology platform supports care management and has shown significant improvements in healthcare outcomes.

    Market Beat·
    US
    ASTH
    -1.57%
    Market Beat·
    US
    ASTH
    -1.57%

    Astrana Health, Inc Updates Corporate Presentation

    On January 12, 2026, Astrana Health, Inc updated its corporate presentation for upcoming conferences. The presentation includes forward-looking statements about business plans and financial projections, focusing on improving patient outcomes, expanding into new markets, and emphasizing value-based care. The company is committed to enhancing care quality while managing costs effectively.

    TradingView·
    US
    ASTH
    -1.57%
    TradingView·
    US
    ASTH
    -1.57%

    Astrana Health, Inc. to Participate in Upcoming Investor Conference | ASTH Stock News

    Astrana Health, Inc. (NASDAQ: ASTH) announced its participation in the J.P. Morgan 2026 Healthcare Conference in San Francisco on January 12, 2026, with a presentation scheduled for 5:15 PM PT. The company focuses on delivering high-quality, patient-centered care through its AI-powered technology and provider networks, supporting over 20,000 providers and 1.6 million patients in value-based care arrangements. More details will be available on their website's IR Calendar section.

    StockTitan·
    US
    ASTH
    -1.57%
    StockTitan·
    US
    ASTH
    -1.57%

    Astrana Health initiated as buy at Needham on valuation

    Needham initiated coverage of Astrana Health (ASTH) with a Buy rating and a $28 price target, citing a valuation disconnect between hospitals and the health tech firm. Analyst Matthew Shea noted Astrana's current trading level is below that of hospital operators and sees shares as undervalued. He highlighted the company's integration of hospital operations into its value-based care network and its superior growth profile and margin potential.

    MSN·
    US
    ASTH
    -1.57%
    MSN·
    US
    ASTH
    -1.57%
    © 2026 Longbridge｜Disclaimer